The Australian government has accumulated $365 million for a fund that will support small businesses. Private equity investors are unsure why it’s necessary and how it will be managed
Launched in 2011 with GBP2.5 billion (then $4 billion) in funding from five major banks, the UK’s Business Growth Fund had invested GBP2 billion in 285 companies across retail, energy, hospitality, engineering...
Suzhou Medilink Therapeutics, a Chinese biotech company specializing in antibody-drug conjugates (ADCs) commonly used as targeted therapies for treating cancer, has raised $50 million in Series A funding across two tranches.
OrbiMed has closed its latest Asia life sciences fund, which primarily invests in China and India, with $800 million in commitments.
Tuya, a Chinese software platform for internet-of-things (IoT) systems that mainly offers platform-as-a-service (PaaS) products is pursuing a US IPO.